What Clinical Strategies Are Applied for Botulinum Toxin Injection in the Oromandibular Region?

Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

Documents

  • 51448

    Final published version, 5 MB, PDF document

Merete Bakke, Torben Dalager, Eigild Møller

Botulinum neurotoxin (BoNT) inhibits the release of acetylcholine from cholinergic nerve terminals in muscles or salivary glands. With reduced activation, the muscle activity or secretion decreases. Indications for medical, non‐cosmetic use of BoNT in the orofacial area include among others oromandibular dystonia, painful masseter hypertrophy, Frey's syndrome, and severe drooling. The chapter covers anamnestic characteristics of these conditions as well as clinical, electromyographic (EMG) and laboratory findings, treatment methods with guided injections, and outcome from systematic treatment controls and follow‐up examinations.
Original languageEnglish
Title of host publicationBotulinum Toxin Therapy Manual for Dystonia and Spasticity
EditorsR Rosales, D Dressler
Number of pages17
Place of PublicationRijeka
PublisherInTechOpen
Publication date2016
Pages79-95
Chapter7
ISBN (Print)978-953-51-2852-6
ISBN (Electronic) 978-953-51-2851-9
DOIs
Publication statusPublished - 2016

Number of downloads are based on statistics from Google Scholar and www.ku.dk


No data available

ID: 173415158